|
1
|
Massague J and Obenauf AC: Metastatic
colonization by circulating tumor cells. Nature. 529:298–306. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siravegna G, Marsoni S, Siena S and
Bardelli A: Integrating liquid biopsies into the management of
cancer. Nat Rev Clin Oncol. 14:531–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et
al: Relationship of circulating tumor cells to tumor response,
progression-free survival, and overall survival in patients with
metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Bono JS, Scher HI, Montgomery RB,
Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ
and Raghavan D: Circulating tumor cells predict survival benefit
from treatment in metastatic castration-resistant prostate cancer.
Clin Cancer Res. 14:6302–6309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hayes DF, Cristofanilli M, Budd GT, Ellis
MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV and
Terstappen LW: Circulating tumor cells at each follow-up time point
during therapy of metastatic breast cancer patients predict
progression-free and overall survival. Clin Cancer Res.
12:4218–4224. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang C, Wei C, Wang S, Han S, Shi D, Zhang
C, Lin X, Dou R and Xiong B: Combined features based on
preoperative controlling nutritional status score and circulating
tumor cell status predict prognosis for colorectal cancer patients
treated with curative resection. Int J Biol Sci. 15:1325–1335.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pernot S, Badoual C, Terme M, Castan F,
Cazes A, Bouche O, Bennouna J, Francois E, Ghiringhelli F, De La
Fouchardiere C, et al: Dynamic evaluation of circulating tumor
cells in patients with advanced gastric and oesogastric junction
adenocarcinoma: Prognostic value and early assessment of
therapeutic effects. Eur J Cancer. 79:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang S, Wu T, Peng X, Liu J, Liu F, Wu S,
Liu S, Dong Y, Xie S and Ma S: Mesenchymal phenotype of circulating
tumor cells is associated with distant metastasis in breast cancer
patients. Cancer Manag Res. 9:691–700. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi LN, Xiang BD, Wu FX, Ye JZ, Zhong JH,
Wang YY, Chen YY, Chen ZS, Ma L, Chen J, et al: Circulating tumor
cells undergoing EMT provide a metric for diagnosis and prognosis
of patients with hepatocellular carcinoma. Cancer Res.
78:4731–4744. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang C, Shi D, Wang S, Wei C, Zhang C and
Xiong B: Prognostic value of pre- and post-operative circulating
tumor cells detection in colorectal cancer patients treated with
curative resection: A prospective cohort study based on ISET
device. Cancer Manag Res. 10:4135–4144. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chaffer CL, San Juan BP, Lim E and
Weinberg RA: EMT, cell plasticity and metastasis. Cancer Metastasis
Rev. 35:645–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas
ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al:
Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science. 339:580–584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin X, Wang S, Sun M, Zhang C, Wei C, Yang
C, Dou R, Liu Q and Xiong B: miR-195-5p/NOTCH2-mediated EMT
modulates IL-4 secretion in colorectal cancer to affect M2-like TAM
polarization. J Hematol Oncol. 12:202019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei C, Yang C, Wang S, Shi D, Zhang C, Lin
X, Liu Q, Dou R and Xiong B: Crosstalk between cancer cells and
tumor associated macrophages is required for mesenchymal
circulating tumor cell-mediated colorectal cancer metastasis. Mol
Cancer. 18:642019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang C, Wei C, Wang S, Shi D, Zhang C, Lin
X, Dou R and Xiong B: Elevated CD163+/CD68+
ratio at tumor invasive front is closely associated with aggressive
phenotype and poor prognosis in colorectal cancer. Int J Biol Sci.
15:984–998. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Micalizzi DS, Haber DA and Maheswaran S:
Cancer metastasis through the prism of epithelial-to-mesenchymal
transition in circulating tumor cells. Mol Oncol. 11:770–780. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Li S, Li W, Yang R, Zhang X, Ye Y,
Yu J, Ye L and Tang W: Circulating tumor cells undergoing EMT are
poorly correlated with clinical stages or predictive of recurrence
in hepatocellular carcinoma. Sci Rep. 9:70842019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Zhang X, Ge S, Gao J, Gong J, Lu M,
Zhang Q, Cao Y, Wang DD, Lin PP and Shen L: Clinical significance
of phenotyping and karyotyping of circulating tumor cells in
patients with advanced gastric cancer. Oncotarget. 5:6594–6602.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morrow CJ, Trapani F, Metcalf RL,
Bertolini G, Hodgkinson CL, Khandelwal G, Kelly P, Galvin M, Carter
L, Simpson KL, et al: Tumorigenic non-small-cell lung cancer
mesenchymal circulating tumor cells: A clinical case study. Ann
Oncol. 27:1155–1160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen Q, Xu L, Zhao L, Wu D, Fan Y, Zhou Y,
Ouyang WH, Xu X, Zhang Z, Song M, et al: Specific capture and
release of circulating tumor cells using aptamer-modified
nanosubstrates. Adv Mater. 25:2368–2373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng B, He Z, Zhao L, Fang Y, Chen Y, He
R, Chen F, Song H, Deng Y, Zhao X and Xiong B: Transparent,
biocompatible nanostructured surfaces for cancer cell capture and
culture. Int J Nanomedicine. 9:2569–2580. 2014.PubMed/NCBI
|
|
23
|
Wang S, Zhang C, Wang G, Cheng B, Wang Y,
Chen F, Chen Y, Feng M and Xiong B: Aptamer-mediated
transparent-biocompatible nanostructured surfaces for
hepotocellular circulating tumor cells enrichment. Theranostics.
6:1877–1886. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang C, Zhang N, Wang S, Shi D, Zhang C,
Liu K and Xiong B: Wedge-shaped microfluidic chip for circulating
tumor cells isolation and its clinical significance in gastric
cancer. J Transl Med. 16:1392018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Austin RG, Huang TJ, Wu M, Armstrong AJ
and Zhang T: Clinical utility of non-EpCAM based circulating tumor
cell assays. Adv Drug Deliv Rev. 125:132–142. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen Z, Wu A and Chen X: Current detection
technologies for circulating tumor cells. Chem Soc Rev.
46:2038–2056. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen F, Wang S, Fang Y, Zheng L, Zhi X,
Cheng B, Chen Y, Zhang C, Shi D, Song H, et al: Feasibility of a
novel one-stop ISET device to capture CTCs and its clinical
application. Oncotarget. 8:3029–3041. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang D, Zhao L, Zhou P, Ma H, Huang F,
Jin M, Dai X, Zheng X, Huang S and Zhang T: Circulating tumor
microemboli (CTM) and vimentin+ circulating tumor cells (CTCs)
detected by a size-based platform predict worse prognosis in
advanced colorectal cancer patients during chemotherapy. Cancer
Cell Int. 17:62017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vona G, Sabile A, Louha M, Sitruk V,
Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, et
al: Isolation by size of epithelial tumor cells: A new method for
the immunomorphological and molecular characterization of
circulatingtumor cells. Am J Pathol. 156:57–63. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hofman VJ, Ilie MI, Bonnetaud C, Selva E,
Long E, Molina T, Vignaud JM, Fléjou JF, Lantuejoul S, Piaton E, et
al: Cytopathologic detection of circulating tumor cells using the
isolation by size of epithelial tumor cell method: Promises and
pitfalls. Am J Clin Pathol. 135:146–156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hou JM, Krebs M, Ward T, Sloane R, Priest
L, Hughes A, Clack G, Ranson M, Blackhall F and Dive C: Circulating
tumor cells as a window on metastasis biology in lung cancer. Am J
Pathol. 178:989–996. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Deevi RK, Javadi A, McClements J,
Vohhodina J, Savage K, Loughrey MB, Evergren E and Campbell FC:
Protein kinase C zeta suppresses low- or high-grade colorectal
cancer (CRC) phenotypes by interphase centrosome anchoring. J
Pathol. 244:445–459. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: Emt: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jie XX, Zhang XY and Xu CJ:
Epithelial-to-mesenchymal transition, circulating tumor cells and
cancer metastasis: Mechanisms and clinical applications.
Oncotarget. 8:81558–81571. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Krebs MG, Renehan AG, Backen A, Gollins S,
Chau I, Hasan J, Valle JW, Morris K, Beech J, Ashcroft L, et al:
Circulating tumor cell enumeration in a phase II trial of a
four-drug regimen in advanced colorectal cancer. Clin Colorectal
Cancer. 14:115–122.e1-e2. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsai WS, Chen JS, Shao HJ, Wu JC, Lai JM,
Lu SH, Hung TF, Chiu YC, You JF, Hsieh PS, et al: Circulating tumor
cell count correlates with colorectal neoplasm progression and is a
prognostic marker for distant metastasis in non-metastatic
patients. Sci Rep. 6:245172016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rahbari NN, Aigner M, Thorlund K, Mollberg
N, Motschall E, Jensen K, Diener MK, Büchler MW, Koch M and Weitz
J: Meta-analysis shows that detection of circulating tumor cells
indicates poor prognosis in patients with colorectal cancer.
Gastroenterology. 138:1714–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang ZL, Zhang P, Li HC, Yang XJ, Zhang
YP, Li ZL, Xue L, Xue YQ, Li HL, Chen Q and Chong T: Dynamic
changes of different phenotypic and genetic circulating tumor cells
as a biomarker for evaluating the prognosis of RCC. Cancer Biol
Ther. 20:505–512. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Markiewicz A, Topa J, Nagel A, Skokowski
J, Seroczynska B, Stokowy T, Welnicka-Jaskiewicz M and Zaczek AJ:
Spectrum of Epithelial-mesenchymal transition phenotypes in
circulating tumor cells from early breast cancer patients. Cancers
(Basel). 11(pii): E592019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu L, Mao X, Guo T, Chan PY, Shaw G, Hines
J, Stankiewicz E, Wang Y, Oliver RTD, Ahmad AS, et al: The Novel
Association of circulating tumor cells and circulating
megakaryocytes with prostate cancer prognosis. Clin Cancer Res.
23:5112–5122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tiwari N, Gheldof A, Tatari M and
Christofori G: EMT as the ultimate survival mechanism of cancer
cells. Semin Cancer Biol. 22:194–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cao Z, Livas T and Kyprianou N: Anoikis
and EMT: Lethal ‘Liaisons’ during cancer progression. Crit Rev
Oncog. 21:155–168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Frisch SM, Schaller M and Cieply B:
Mechanisms that link the oncogenic epithelial-mesenchymal
transition to suppression of anoikis. J Cell Sci. 126:21–29. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sayan AE, Griffiths TR, Pal R, Browne GJ,
Ruddick A, Yagci T, Edwards R, Mayer NJ, Qazi H, Goyal S, et al:
SIP1 protein protects cells from DNA damage-induced apoptosis and
has independent prognostic value in bladder cancer. Proc Natl Acad
Sci USA. 106:14884–14889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Smit MA and Peeper DS: Zeb1 is required
for TrkB-induced epithelial-mesenchymal transition, anoikis
resistance and metastasis. Oncogene. 30:3735–3744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sharma S, Zhuang R, Long M, Pavlovic M,
Kang Y, Ilyas A and Asghar W: Circulating tumor cell isolation,
culture, and downstream molecular analysis. Biotechnol Adv.
36:1063–1078. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen L, Bode AM and Dong Z: Circulating
tumor cells: Moving biological insights into detection.
Theranostics. 7:2606–2619. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gross HJ, Verwer B, Houck D, Hoffman RA
and Recktenwald D: Model study detecting breast cancer cells in
peripheral blood mononuclear cells at frequencies as low as 10(−7).
Proc Natl Acad Sci USA. 92:537–541. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang C, Zou K, Zheng L and Xiong B:
Prognostic and clinicopathological significance of circulating
tumor cells detected by RT-PCR in non-metastatic colorectal cancer:
A meta-analysis and systematic review. BMC Cancer. 17:7252017.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ghossein RA, Bhattacharya S and Rosai J:
Molecular detection of micrometastases and circulating tumor cells
in solid tumors. Clin Cancer Res. 5:1950–1960. 1999.PubMed/NCBI
|
|
53
|
Shahneh FZ: Sensitive antibody-based CTCs
detection from peripheral blood. Hum Antibodies. 22:51–54. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hao SJ, Wan Y, Xia YQ, Zou X and Zheng SY:
Size-based separation methods of circulating tumor cells. Adv Drug
Deliv Rev. 125:3–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Riethdorf S, O'Flaherty L, Hille C and
Pantel K: Clinical applications of the CellSearch platform in
cancer patients. Adv Drug Deliv Rev. 125:102–121. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Andree KC, van Dalum G and Terstappen LW:
Challenges in circulating tumor cell detection by the CellSearch
system. Mol Oncol. 10:395–407. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lecharpentier A, Vielh P, Perez-Moreno P,
Planchard D, Soria JC and Farace F: Detection of circulating tumor
cells with a hybrid (epithelial/mesenchymal) phenotype in patients
with metastatic non-small cell lung cancer. Br J Cancer.
105:1338–1341. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Friedlander TW, Ngo VT, Dong H,
Premasekharan G, Weinberg V, Doty S, Zhao Q, Gilbert EG, Ryan CJ,
Chen WT and Paris PL: Detection and characterization of invasive
circulating tumor cells derived from men with metastatic
castration-resistant prostate cancer. Int J Cancer. 134:2284–2293.
2014. View Article : Google Scholar : PubMed/NCBI
|
